Sinovac, Sinopharm show safety, efficacy: WHO
GENEVA -- Chinese vaccine makers Sinopharm and Sinovac have presented data on their COVID-19 vaccines demonstrating safety and good efficacy against symptomatic COVID-19 disease, a vaccine expert from the World Health Organization (WHO) has said recently.
During a news briefing on March 31, Alejandro Cravioto, chair of the WHO Strategic Advisory Group of Experts on Immunization (SAGE), said the information that the companies shared publicly at the SAGE meeting last week clearly indicates "they have levels of efficacy that would be compatible with the requirements that WHO has asked for this vaccine."
"They have all the safety data to show that this vaccine would cause no harm in humans when used," Cravioto added.
- China Medical Expert Team arrives in DR Congo to aid battle against Ebola, leveraging expertise and China's experience in epidemic control: team members
- China to send medical expert team to DR Congo for Ebola control
- Senior WHO official highlights China's role in tackling global health challenges
- Focus on the World Health Assembly | Healthy China, not just China
- China builds robust nursing workforce amid healthcare push
- NHC minister meets with president of Merieux Foundation


